Suzhou, China

Yan Sun

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Lisure Science (Suzhou) Co., Ltd., Suzhou Smartnuclide Biopharmaceutical Co., Ltd.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yan Sun. Retrieved from https://idiyas.com/inventor/yan-sun-ebnc06cc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yan Sun - Innovator in Biomedicine

Introduction

Yan Sun is a prominent inventor based in Suzhou, China. She has made significant contributions to the field of biomedicine, particularly in the development of innovative polypeptides.

Latest Patents

Yan Sun holds a patent for a PD-L1-binding polypeptide and its applications. This invention is crucial for detecting and diagnosing PD-L1 related diseases, including various forms of cancer. Her work in this area highlights the importance of biomedicine in advancing healthcare solutions.

Career Highlights

Yan Sun is associated with Suzhou Smartnuclide Biopharmaceutical Co., Ltd., where she continues to push the boundaries of medical research. Her dedication to innovation has led to the development of groundbreaking technologies that can potentially save lives.

Collaborations

She collaborates with talented individuals such as Tao Xu and Hao Qi, who contribute to her research efforts and enhance the impact of her work.

Conclusion

Yan Sun's contributions to biomedicine through her innovative patents exemplify the vital role of inventors in advancing healthcare. Her work not only addresses critical medical challenges but also inspires future innovations in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…